Stock listing

Inmed Pharmaceuticals Inc.

Selected listing: A40UCN · LS · EUR · DE

Inmed Pharmaceuticals Inc. (Lang & Schwarz: A40UCN), Health Technology. Latest release Sep 18, 2026: InMed Pharmaceuticals Receives Nasdaq Notification…

A40UCN:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A40UCN
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Inmed Pharmaceuticals Inc.

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Shareholders' Equity Compliance

September 18, 2026

InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update

September 9, 2026

InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4

July 6, 2026

InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements

June 4, 2026

/C O R R E C T I O N -- InMed Pharmaceuticals/

May 19, 2026

All Inmed Pharmaceuticals Inc. news →

Events

Replays

InMed Pharmaceuticals Inc. (INM) Q4 2022 Earnings Call
Fri, Sep 23, 2022 · 01:00 PM ET
Watch
InMed Pharmaceuticals Inc. (INM) Q2 2022 Earnings Call
Tue, Feb 15, 2022 · 02:00 PM ET
Watch
InMed Pharmaceuticals Inc. (INM) Q3 2021 Earnings Call
Thu, May 13, 2021 · 11:00 AM ET
Watch

Research Inmed Pharmaceuticals Inc.

Inmed Pharmaceuticals Inc. company profile

View the public company page for Inmed Pharmaceuticals Inc. on 6ix.

Inmed Pharmaceuticals Inc. news

Read company news and market updates connected to Inmed Pharmaceuticals Inc..

Inmed Pharmaceuticals Inc. investor events

Find investor webinars, events, and replay context for Inmed Pharmaceuticals Inc..